Since its establishment in 2010, Cyfuse has been in business with the mission of making social contributions in the medical field, including the fields of regenerative medicine and drug discovery, by generating steric tissues and organs composed “solely of cells.”
Our company “Cyfuse,” which means “Cells (Cyto) are Fused (Fusion),” creates tissues and organs through cell fusion, and has been engaged in creating a business similar to how everyone in our company has fused together in various ways.
One of the goals of Cyfuse has been to ensure that steric tissues and organs—created with the use of “spheroids (cell clusters)” obtained via the phenomenon of cell aggregation as well as with the use of the cell plate “Bio 3D Printer”—are put to practical use as cellular products and are made available to patients. We are also working on developing this Japanese technology on a global scale as well as becoming a leading company in the field of regenerative medicine in the near future.
As we rely on the help of our stakeholders and others to make new therapies and treatment options available to the public as soon as possible, and transform aspirations that we have firmly held since our founding into a concreate reality, all of us in the company will go on doing the utmost to work together every day toward new horizons, and we look forward to your guidance and advice in the future.